Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
107.50
-0.50 (-0.46%)
Apr 20, 2026, 1:24 PM CST
68.23% (1Y)
| Market Cap | 168.09B +24.2% |
| Revenue (ttm) | 38.04M -6.0% |
| Net Income | -284.11M |
| EPS | -0.18 |
| Shares Out | 1.56B |
| PE Ratio | n/a |
| Forward PE | 34.70 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 101,000 |
| Average Volume | 16,990,910 |
| Open | 110.00 |
| Previous Close | 108.00 |
| Day's Range | 107.00 - 113.00 |
| 52-Week Range | 58.10 - 277.00 |
| Beta | 1.37 |
| RSI | 45.64 |
| Earnings Date | May 5, 2026 |